Prototype
Calvin-40
Wandercraft
PrivateFrench robotics company leveraging self-balancing exoskeleton technology to build next-generation industrial humanoid robots.
Founded 2012$75M raised
French robotics company leveraging self-balancing exoskeleton technology to build next-generation industrial humanoid robots.
Wandercraft is a Paris-based robotics company developing self-balancing robotic exoskeletons and next-generation humanoid robots. Founded in 2012, the company initially focused on restoring mobility for people with walking disabilities through advanced lower-limb exoskeletons before expanding its expertise into industrial robotics. Leveraging more than a decade of experience in dynamic balance, locomotion, and human-robot interaction, Wandercraft is applying its control technologies to industrial humanoid robots designed for manufacturing and logistics. Backed by a $75 million Series D led by investors including Renault Group, Bpifrance, and the European Investment Bank, the company is positioned at the intersection of medical robotics and humanoid automation.
Platform maturity, autonomy stack, and flagship-system specifications in one view.
A concise view of platform maturity and deployment footprint.
Capabilities and model layers highlighted by the company.
The company plans a 2026 market launch of the Eve exoskeleton for home use, alongside scaling Calvin-40 production for industrial customers.
Wandercraft was founded in 2012 in Paris with a focus on self-balancing exoskeletons for medical rehabilitation. The company developed Atalante, a self-stabilizing exoskeleton enabling paraplegic patients to walk without crutches, used in hospitals across Europe.
In 2025, Wandercraft pivoted to industrial robotics, unveiling Calvin-40, an industrial-grade humanoid robot developed in just 40 days using their existing walking platform integrated with NVIDIA Isaac technologies. The robot is designed for physically demanding factory tasks.
In June 2025, Wandercraft raised $75 million in Series D funding. Renault Group took a minority stake, becoming both a commercial partner and the first customer of Calvin-40, with deployment planned at Renault EV manufacturing plants.
The company plans a 2026 market launch of the Eve exoskeleton for home use, alongside scaling Calvin-40 production for industrial customers.
Wandercraft is a Paris-based robotics company developing self-balancing exoskeletons and industrial humanoid robots. Founded in 2012, the company raised $75M in Series D funding backed by Renault Group, Bpifrance, and the European Investment Bank.
